Cumberland Pharmaceuticals Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Cumberland Pharmaceuticals Inc. (CPIX) had Stockholders' Equity Attributable to Noncontrolling Interest of -$331.56 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$331.56K.
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$333.51K.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$336.10K.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$319.15K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | -$331.56K 10-Q · filed 2026-08-07 |
| 2026-03-31 | -$333.51K 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$336.10K 10-Q · filed 2026-08-07 |
| 2025-09-30 | -$319.15K 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$310.87K 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$316.40K 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$307.52K 10-K · filed 2026-03-09 |
| 2024-09-30 | -$309.69K 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$316.81K 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$299.78K 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$343.57K 10-K · filed 2025-03-07 |
| 2023-09-30 | -$335.99K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$322.07K 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$312.02K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$292.13K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$273.14K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$258.55K 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$229.51K 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$212.33K 10-K · filed 2023-03-13 |
| 2021-09-30 | -$175.77K 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$144.35K 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$139.28K 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$117.12K 10-K · filed 2022-03-11 |
| 2020-09-30 | -$85.43K 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$69.46K 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$47.15K 10-Q · filed 2020-05-22 |
| 2019-12-31 | -$37.62K 10-K · filed 2021-03-12 |
| 2019-09-30 | -$25.98K 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$372.31K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$240.81K 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$274.27K 8-K · filed 2020-12-10 |
| 2018-09-30 | -$257.25K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$236.27K 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$211.51K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$198.56K 10-K · filed 2019-03-12 |
| 2017-09-30 | -$177.30K 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$163.09K 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$146.50K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$127.38K 10-K · filed 2018-03-09 |
| 2016-09-30 | -$107.14K 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$96.47K 10-Q · filed 2016-08-05 |
| 2016-03-31 | -$83.57K 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$68.13K 10-K · filed 2017-03-13 |
| 2015-09-30 | -$45.66K 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$39.35K 10-Q · filed 2015-08-07 |
| 2015-03-31 | -$27.65K 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$7.88K 10-K · filed 2016-03-14 |
| 2014-09-30 | -$217.55K 10-Q · filed 2014-11-07 |
| 2014-06-30 | -$200.81K 10-Q · filed 2014-08-08 |
| 2014-03-31 | -$187.78K 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$176.64K 10-K · filed 2015-03-09 |
| 2013-09-30 | -$165.61K 10-Q · filed 2013-11-06 |
| 2013-06-30 | -$153.05K 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$143.22K 10-Q · filed 2013-05-08 |
| 2012-12-31 | -$129.83K 10-K · filed 2014-03-11 |
| 2012-09-30 | -$118.29K 10-Q · filed 2012-11-02 |
| 2012-06-30 | -$110.95K 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$102.92K 10-Q · filed 2012-05-04 |
| 2011-12-31 | -$93.55K 10-K · filed 2013-03-12 |
| 2011-09-30 | -$90.01K 10-Q · filed 2011-11-07 |
| 2011-06-30 | -$81.55K 10-Q · filed 2011-08-08 |
| 2010-12-31 | -$62.20K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |